These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

714 related articles for article (PubMed ID: 15541117)

  • 1. Determinants of long-term quality of life and voiding function of patients treated with radical prostatectomy or permanent brachytherapy for prostate cancer.
    Bradley EB; Bissonette EA; Theodorescu D
    BJU Int; 2004 Nov; 94(7):1003-9. PubMed ID: 15541117
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radical prostatectomy versus high-dose rate brachytherapy for prostate cancer: effects on health-related quality of life.
    Jo Y; Junichi H; Tomohiro F; Yoshinari I; Masato F
    BJU Int; 2005 Jul; 96(1):43-7. PubMed ID: 15963118
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of a novel neoadjuvant and adjuvant hormone-deprivation approach on quality of life, voiding function, and sexual function after prostate brachytherapy.
    Miller NL; Bissonette EA; Bahnson R; Wilson J; Theodorescu D
    Cancer; 2003 Mar; 97(5):1203-10. PubMed ID: 12599226
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Permanent 125I-seed brachytherapy or radical prostatectomy: a prospective comparison considering oncological and quality of life results.
    Borchers H; Kirschner-Hermanns R; Brehmer B; Tietze L; Reineke T; Pinkawa M; Eble MJ; Jakse G
    BJU Int; 2004 Oct; 94(6):805-11. PubMed ID: 15476513
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quality-of-life comparison of radical prostatectomy and interstitial brachytherapy in the treatment of clinically localized prostate cancer.
    Krupski T; Petroni GR; Bissonette EA; Theodorescu D
    Urology; 2000 May; 55(5):736-42. PubMed ID: 10792092
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Health-related quality of life 2 years after treatment with radical prostatectomy, prostate brachytherapy, or external beam radiotherapy in patients with clinically localized prostate cancer.
    Ferrer M; Suárez JF; Guedea F; Fernández P; Macías V; Mariño A; Hervas A; Herruzo I; Ortiz MJ; Villavicencio H; Craven-Bratle J; Garin O; Aguiló F;
    Int J Radiat Oncol Biol Phys; 2008 Oct; 72(2):421-32. PubMed ID: 18325680
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Health-related quality of life after radical prostatectomy and low-dose-rate brachytherapy for localized prostate cancer.
    Wyler SF; Engeler DS; Seelentag W; Ries G; Schmid HP
    Urol Int; 2009; 82(1):17-23. PubMed ID: 19172091
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Five-year outcomes after prostatectomy or radiotherapy for prostate cancer: the prostate cancer outcomes study.
    Potosky AL; Davis WW; Hoffman RM; Stanford JL; Stephenson RA; Penson DF; Harlan LC
    J Natl Cancer Inst; 2004 Sep; 96(18):1358-67. PubMed ID: 15367568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An assessment of quality of life following radical prostatectomy, high dose external beam radiation therapy and brachytherapy iodine implantation as monotherapies for localized prostate cancer.
    Frank SJ; Pisters LL; Davis J; Lee AK; Bassett R; Kuban DA
    J Urol; 2007 Jun; 177(6):2151-6; discussion 2156. PubMed ID: 17509305
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quality of life after brachytherapy or radical prostatectomy for localized prostate cancer: a prospective longitudinal study.
    Namiki S; Satoh T; Baba S; Ishiyama H; Hayakawa K; Saito S; Arai Y
    Urology; 2006 Dec; 68(6):1230-6. PubMed ID: 17141839
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term outcomes among localized prostate cancer survivors: health-related quality-of-life changes after radical prostatectomy, external radiation, and brachytherapy.
    Miller DC; Sanda MG; Dunn RL; Montie JE; Pimentel H; Sandler HM; McLaughlin WP; Wei JT
    J Clin Oncol; 2005 Apr; 23(12):2772-80. PubMed ID: 15837992
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radical prostatectomy for localized prostate cancer provides durable cancer control with excellent quality of life: a structured debate.
    Walsh PC
    J Urol; 2000 Jun; 163(6):1802-7. PubMed ID: 10799186
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Health related quality of life patterns in patients treated with interstitial prostate brachytherapy for localized prostate cancer--data from CaPSURE.
    Downs TM; Sadetsky N; Pasta DJ; Grossfeld GD; Kane CJ; Mehta SS; Carroll PR; Lubeck DP
    J Urol; 2003 Nov; 170(5):1822-7. PubMed ID: 14532784
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A 3-y prospective study of health-related and disease-specific quality of life in patients with nonmetastatic prostate cancer treated with radical prostatectomy or external beam radiotherapy.
    Yoshimura K; Arai Y; Ichioka K; Matsui Y; Ogura K; Terai A
    Prostate Cancer Prostatic Dis; 2004; 7(2):144-51. PubMed ID: 15111981
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quality of life outcomes after brachytherapy for early stage prostate cancer.
    Brandeis JM; Litwin MS; Burnison CM; Reiter RE
    J Urol; 2000 Mar; 163(3):851-7. PubMed ID: 10687991
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prospective assessment of voiding and sexual function after treatment for localized prostate carcinoma: comparison of radical prostatectomy to hormonobrachytherapy with and without external beam radiotherapy.
    Fulmer BR; Bissonette EA; Petroni GR; Theodorescu D
    Cancer; 2001 Jun; 91(11):2046-55. PubMed ID: 11391584
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expanded Prostate Cancer Index Composite versus Incontinence Symptom Index and Sexual Health Inventory for Men to measure functional outcomes after prostatectomy.
    Hedgepeth RC; Labo J; Zhang L; Wood DP
    J Urol; 2009 Jul; 182(1):221-7; discussion 227-8. PubMed ID: 19450842
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early quality of life assessment in men treated with permanent source interstitial brachytherapy for clinically localized prostate cancer.
    Lee WR; McQuellon RP; Case LD; deGuzman AF; McCullough DL
    J Urol; 1999 Aug; 162(2):403-6. PubMed ID: 10411047
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quality of life impact of treatments for localized prostate cancer: cohort study with a 5 year follow-up.
    Ferrer M; Guedea F; Suárez JF; de Paula B; Macías V; Mariño A; Hervás A; Herruzo I; Ortiz MJ; Ponce de León J; Sancho G; Boladeras A; Ayala A; Craven-Bratle J; Ávila M; Cunillera O; Pardo Y; Alonso J; Aguiló F;
    Radiother Oncol; 2013 Aug; 108(2):306-13. PubMed ID: 23849168
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Survivorship beyond convalescence: 48-month quality-of-life outcomes after treatment for localized prostate cancer.
    Gore JL; Kwan L; Lee SP; Reiter RE; Litwin MS
    J Natl Cancer Inst; 2009 Jun; 101(12):888-92. PubMed ID: 19509365
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.